Baguinda, Mark Daniel A.
HRN: 28-62-91 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2026
CEFUROXIME 750MG (VIAL)
02/28/2026
03/07/2026
IV
430MG
Q8
PCAP C
Checking Initial Appropriateness
03/03/2026
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
03/03/2026
03/07/2026
ORAL
3ml
OD
PCAP-C
Checking Initial Appropriateness